Nucleovir Therapeutics

Nucleovir Therapeutics is focused on redefining immuno-oncology through innovative biotechnology research

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Nucleovir Therapeutics is focused on redefining immuno-oncology through innovative biotechnology research.

02Backed By1 investor

03Recent Activity

Invested in Nucleovir Therapeutics, an oncolytic-virus cancer immunotherapy company.

INVESTMENT·specialeinvest.com

JUN 11, 2026

04Similar Companies

JT

TT

M

XT

GB

05Startup DNA

5

signals

Sectors
Business Model
Technology